SCHEMBL31110302

SCHEMBL31110302

Nc1c(C(=O)O)oc2ccc(-c3cccc(-c4ccc(-c5ccccc5)cc4)c3)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
RAB9A P51151 3/20 0.50
MAPT P10636 3/20 0.50
ADORA2A P29274 1/20 0.50
CASP1 P29466 1/20 0.50
TBK1 Q9UHD2 1/20 0.49
KDM4E B2RXH2 6/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 4/20 0.46
HPGD P15428 4/20 0.46
HSD17B10 Q99714 3/20 0.46
PLA2G2A P14555 4/20 0.45
PLA2G4A P47712 4/20 0.45
PLA2G10 O15496 1/20 0.45
KMO O15229 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23610605 0.97 NPC1 (0.52) NPC1SMN1; SMN2RAB9AMAPTADORA2A
SCHEMBL20535044 0.87 KDM4E (0.61) NPC1SMN1; SMN2RAB9AMAPTADORA2A
SCHEMBL3498056 0.85 KDM4E (0.60) NPC1SMN1; SMN2RAB9AMAPTADORA2A
SCHEMBL9217459 0.83 PTPN1 (0.50) RAB9AMAPTTBK1KDM4EHPGD
SCHEMBL24055231 0.82 KDM4E (0.67) NPC1SMN1; SMN2RAB9AMAPTKDM4E
SCHEMBL10374396 0.80 PLA2G2A (0.47) NPC1RAB9AMAPTTBK1KDM4E
SCHEMBL1444187 0.79 MCL1 (0.63) SMN1; SMN2KDM4EKMT2AALDH1A1HPGD
SCHEMBL23610617 0.79 KDM4E (0.70) NPC1SMN1; SMN2RAB9AMAPTKDM4E
SCHEMBL28467236 0.78 KDM4E (0.53) NPC1SMN1; SMN2RAB9AMAPTADORA2A
SCHEMBL2774740 0.77 MAPT (0.72) NPC1SMN1; SMN2RAB9AMAPTADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250002500-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-01-02 US disclosed
US-12091416-B2 Organic compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2024-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250002500-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device AHR, CYP1A1, ARNT NPC1 4334/4885SMN1; SMN2 4252/4885RAB9A 3721/4885
US-12091416-B2 Organic compound TPD52L2, COXFA4, DBF4 NPC1 3292/4885SMN1; SMN2 3610/4885RAB9A 4227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.